$3.08
-0.02-0.65%
Pre-Market: Nov 22, 5:46 PM EDT
Comments
Loading...
Pasithea Therapeutics (KTTA) Forecast
NewsEarningsPasithea Therapeutics (KTTA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPasithea Therapeutics (NASDAQ:KTTA) Stock Quotes, Forecast and News Summary
Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pasithea Therapeutics (KTTA) stock?
You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.
Who are Pasithea Therapeutics (KTTA) competitors?
Other companies in Pasithea Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Pasithea Therapeutics (KTTA) stock?
Pasithea Therapeutics has a consensus price target of $2.00.
What is the current price for Pasithea Therapeutics (KTTA)?
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $3.08 last updated November 22, 2024 at 5:46 PM EST.
Does Pasithea Therapeutics (KTTA) pay a dividend?
There are no upcoming dividends for Pasithea Therapeutics.
When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?
Pasithea Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Pasithea Therapeutics (KTTA) going to split?
There is no upcoming split for Pasithea Therapeutics.
What sector and industry does Pasithea Therapeutics (KTTA) operate in?
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.